Efficacy and Safety Study of MC-1101 1% TID in the Treatment of Nonexudative Age-Related Macular Degeneration

NCT01601483 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

22

Enrollment

INDUSTRY

Sponsor class

Stopped Unmasked without Sponsor's prior knowledge or authorization by the PI.

Conditions

Nonexudative Age Related Macular Degeneration

Interventions

DRUG: MC-1101
DRUG: MC-1101 Vehicle

Sponsor

MacuCLEAR, Inc.